269 related articles for article (PubMed ID: 6309884)
1. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
[TBL] [Abstract][Full Text] [Related]
2. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
[TBL] [Abstract][Full Text] [Related]
3. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
4. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
Braley LM; Menachery A; Rystedt L; Williams GH
Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
[TBL] [Abstract][Full Text] [Related]
5. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
Gordon MB; Moore TJ; Dluhy RG; Williams GH
J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
[TBL] [Abstract][Full Text] [Related]
7. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
Taylor T; Moore TJ; Hollenberg NK; Williams GH
Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
[TBL] [Abstract][Full Text] [Related]
8. Plasma aldosterone response to angiotensin II in sodium-restricted elderly subjects with essential hypertension.
Morimoto S; Uchida K; Miyamoto M; Kigoshi T; Morise T; Takimoto H; Takeda R
J Am Geriatr Soc; 1981 Jul; 29(7):302-7. PubMed ID: 7016959
[TBL] [Abstract][Full Text] [Related]
9. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
Anderson GH; Howland T; Domschek R; Streeten DH
J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
Hollenberg NK; Chenitz WR; Adams DF; Williams GH
J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
[TBL] [Abstract][Full Text] [Related]
12. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone.
Semple PF; Nicholls MG; Tree M; Fraser R
Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159
[TBL] [Abstract][Full Text] [Related]
13. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
Wilkes BM
J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.
Takeda R; Morimoto S; Uchida K; Hashiba T; Kigoshi T; Honjo A; Fujimura A
Clin Exp Hypertens A; 1982; 4(6):937-49. PubMed ID: 7047005
[TBL] [Abstract][Full Text] [Related]
16. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
17. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
18. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
19. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
Speckart P; Zia P; Zipser R; Horton R
J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
[TBL] [Abstract][Full Text] [Related]
20. Prolonged infusions of Ile5-angiotensin-II in sodium replete and deplete man: effects on aldosterone, ACTH, cortisol, blood pressure, and electrolyte balance.
Oelkers W; Schöneshöfer M; Schultze G; Wenzler M; Bauer B; L'age M; Fehm HL
J Clin Endocrinol Metab; 1978 Mar; 46(3):402-13. PubMed ID: 221518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
